Full Breakdown
Withings Launches Body Scan 2: A Comprehensive Health Monitoring Scale
1/5/2026, 11:03:28 AM
Overview of the Body Scan 2
At CES 2026 in Las Vegas, Withings unveiled the Body Scan 2, a state-of-the-art smart scale designed to monitor over 60 health biomarkers, including hypertension risk and glycemic dysregulation. Priced at $599.95 in the U.S., this second-generation model builds on its predecessor, which launched in 2023 and tracked 40 biomarkers. The Body Scan 2 aims to provide users with actionable insights into their health, potentially preventing chronic conditions associated with modern lifestyles.
Key Features and Technology
The Body Scan 2 incorporates advanced technologies such as Impedance Cardiography (ICG) and Bioimpedance Spectroscopy (BIS). ICG assesses the heart's pumping efficiency, while BIS evaluates cellular health and metabolic efficiency. Users can complete a full scan in approximately 90 seconds by standing on the scale and holding a retractable handle equipped with additional electrodes. This design allows for a more comprehensive assessment by capturing upper-body data, which is often overlooked by traditional scales.
The scale's AI model analyzes the collected data to notify users of potential health risks, such as high blood pressure and glycemic dysregulation, without the need for traditional blood pressure cuffs. The Body Scan 2 also generates a "Health Trajectory score," which visualizes users' health trends over time, encouraging proactive lifestyle changes.
Regulatory Path and Market Position
Withings is currently seeking FDA clearance for the hypertension risk detection feature and the six-lead ECG functionality. Antoine Joussain, Withings' director of product management, expressed optimism about the regulatory process, noting improvements in how the FDA handles such devices. The Body Scan 2 is expected to launch in the second quarter of 2026, pending clearance.
This product positions Withings as a leader in the smart health monitoring market, competing with other tech giants like Apple and Samsung, which have also ventured into health tracking through wearables. However, Withings differentiates itself by focusing on comprehensive at-home assessments rather than just fitness metrics.
Criticism and Concerns
Despite its innovative features, the Body Scan 2 faces scrutiny regarding the emotional implications of using scales for health monitoring. Some users may experience anxiety or body image issues associated with regular weigh-ins. To address this, Withings has introduced an "Eyes-Closed Mode," which replaces numerical data with emojis during measurements while still recording the data in the app.
Additionally, the scale's reliance on non-invasive methods for health monitoring raises questions about the accuracy and reliability of its readings compared to traditional medical devices.
Conclusion
The Withings Body Scan 2 represents a significant advancement in consumer health technology, aiming to empower users with detailed insights into their cardiovascular and metabolic health. By integrating advanced medical technologies into a user-friendly scale, Withings hopes to encourage preventive health measures and improve overall well-being. As the launch date approaches, the effectiveness of the Body Scan 2 in real-world applications will be closely monitored by both consumers and health professionals alike.
